Abstract
Lymphoma is the most common hematologic malignancy comprising a diverse group of neoplasms arising from multiple blood cell lineages. Any structure of the thorax may be involved at any stage of disease. Imaging has a central role in the initial staging, response assessment, and surveillance of lymphoma, and updated standardized assessment criteria are available to assist with imaging interpretation and reporting. Radiologists should be aware of the modern approaches to lymphoma treatment, the role of imaging in posttherapeutic surveillance, and manifestations of therapy-related complications.
Original language | English (US) |
---|---|
Pages (from-to) | 67-79 |
Number of pages | 13 |
Journal | Journal of Thoracic Imaging |
Volume | 37 |
Issue number | 2 |
DOIs | |
State | Published - Mar 1 2022 |
Keywords
- Adaptive therapy
- Bleomycin toxicity
- Interim positron emission tomography/computed tomography
- Lymphoma
- Response evaluation
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Pulmonary and Respiratory Medicine